Abstract
Facts, figures, forecasts and statistics on pharmaceutical markets and companies around the world.
In today' s challenging market environment the need to understand world
pharmaceutical marketplaces, and be able to answer quickly those questions
that arise daily, is essential. Therefore an authoritative, current and
comprehensive market intelligence source is an invaluable aid for every
executive. And that source is The World Pharmaceutical Markets Fact Book 2009.
Published by Espicom, for over 28 years experts in the healthcare market
field, the 324-page Fact Book brings together a range of often difficult to
source information in one single, convenient and comprehensive publication.
Keep it near to you at all times, or consider an electronic version to share
with colleagues for the search and retrieval of specific information.
Which other business reference provides
- Key economic, demographic and health statistics on 67 markets around the
world
- 5-year forecasts and market valuations
- Over 500 tables and charts
67 key countries covered
- Argentina
- Australia
- Austria
- Bangladesh
- Belarus
- Belgium
- Brazil
- Bulgaria
- Canada
- Chile
- China
- Colombia
- Croatia
- Cuba
- Czech Republic
- Denmark
- Egypt
- Estonia
- Finland
- France
- Germany
- Greece
- Hong Kong
- Hungary
- India
- Indonesia
- Iran
- Ireland
- Israel
- Italy
- Japan
- Jordan
- Latvia
- Lithuania
- Malaysia
- Mexico
- Morocco
- Netherlands
- New Zealand
- Norway
- Oman
- Pakistan
- Peru
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sweden
- Switzerland
- Taiwan
- Thailand
- Turkey
- Ukraine
- UAE
- United Kingdom
- USA
- Venezuela
- Vietnam
Answer questions such as:
- Which country spends the most on pharmaceuticals as % GDP?
- How is the economic downturn and currency fluctuations affecting GDP in
key markets?
- Which phamaceutical markets are growing the fastest?
- How does the Brazilian market compare with Mexico and Argentina in terms
of total health expenditure?
- What demographic development is affecting the market in Central and
Eastern Europe?
- What will the value of the Chines pharmaceutical market be in 2013 and
2014 and what is the growth rate?
|